Leadership Conversations

The Chief Medical Officer for DaVita Kidney Care discusses how the organization is addressing health inequities in the kidney disease population.

The CEO of Blue Cross Blue Shield of Massachusetts describes his work in making population-based contracts a norm in the state and what still needs to be done to improve health care affordability and access.

The Senior Vice President and Senior Associate Dean for Health Equity and Inclusive Excellence for Vanderbilt Medical Center discusses the development of their Racial Equity Plan.

Intellectual disabilities affect 1–3% of the U.S. population. The Executive Vice President and Chief Clinical Officer for Prisma Health discusses how health care redesign should factor in this population to reduce the health disparities they face.

How Priority Health focuses on social determinants of health to meet its members’ unique needs.

The CEO for Texas Health Resources says that “learning has to be done quickly” and describes what his organization has done to meet the needs of their patients and staff.

Hurdles faced by a Chinese American breaking into the C-suite sphere of U.S. health care leadership dominated by white men, the adapting of different cultural values, and advice for younger generations aspiring to the C-suite.

The former CEO of Memorial Hermann Health System, who began his career in nursing, traces the history of the nursing shortage back to the 1970s and offers a selection of solutions for its current iteration, focusing on short-, medium-, and long-term tactics.

If we don’t have equity, we don’t have quality, says the CMO of the Centers for Medicare & Medicaid Services.

Physicians are responsible for making patients feel safe and secure, whether that’s in-person or via a screen.

“It never entered my mind that my gender would be a limiting factor for me,” says the President and CEO of Saint Alphonsus Regional Medical Center.

“I don’t think we can ever look at health care delivery, quality and safety, transformation and work, without having equity at the forefront of everything that we do,” says Eric Wei, MD, MBA, Senior Vice President and Chief Quality Officer for NYC Health + Hospitals.

How the Alternative Quality Contract strives to promote a system that produces health outcomes, not just health care.

The CMO of Montefiore Medical Center explores what they got right during the height of the pandemic — including playing music — and how to apply those learnings in the future.

How the Apollo Hospitals Group handled the intense spike of Covid-19 cases in India, and what they’ve learned from the thousands of families they’ve treated.

Missing important points of view around the C-suite table hurts the organization and the clinical outcomes they are attempting to achieve, says Ron Williams, former chairman and CEO of Aetna.

Naming the challenges and crowdsourcing the strategic plan are two ways Oregon Health & Science University is tackling the ongoing challenges from 2020.

The Chief Medical Officer and Chief Innovation Officer for Sheba Medical Center discusses how Israel was able to keep its case mortality rate low.

It’s not about blaming others, it’s about doing our part to address the inequities and unjust reality we see in health care, says the CEO of Hennepin Healthcare.

Burnout in nursing began long before the Covid-19 pandemic. What will health care leaders learn from the past months to make sure this problem doesn’t continue into the future?

UF Health Jacksonville’s CEO describes the safety-net hospital’s hurricane mindset for sustained Covid-19 pandemic response and leadership efforts such as receiving the vaccine first.

What can health systems and their public health partners execute on now to accelerate and amplify vaccination efforts?

The Executive Vice President and Chief Medical Officer for CVS Health remains optimistic about the United States’ Covid-19 vaccination efforts.

Especially important during a pandemic, health care’s common challenge is making sure how we deliver care and change the structures of society actually contributes to the health of the people we intend to serve.

The pharma industry came together under extraordinary circumstances to develop a vaccine for Covid-19. Biotech and AI will play a major role in what’s to come next.